Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sionna Therapeutics, Inc. - Common Stock
(NQ:
SION
)
35.60
-3.65 (-9.30%)
Streaming Delayed Price
Updated: 11:25 AM EST, Jan 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
56,508
Open
39.03
Bid (Size)
35.40 (100)
Ask (Size)
35.80 (100)
Prev. Close
39.25
Today's Range
34.80 - 39.03
52wk Range
7.255 - 45.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million
↗
January 03, 2026
This clinical-stage biotech focused on cystic fibrosis therapies reported a notable insider sale amid a year of sharp ownership reductions.
Via
The Motley Fool
Topics
Regulatory Compliance
Performance
YTD
-9.2%
-9.2%
1 Month
-16.8%
-16.8%
3 Month
+21.5%
+21.5%
6 Month
+78.5%
+78.5%
1 Year
+42.4%
+42.4%
More News
Read More
Sionna Therapeutics to Participate in Upcoming December Investor Conferences
November 24, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Short Squeeze Fades As Raymond James Backs Cystic Fibrosis Breakthrough, RBC Warns Treatments Set High Bar
↗
September 08, 2025
Via
Stocktwits
Sionna Therapeutics Reports Third Quarter 2025 Financial Results
November 05, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics to Participate in Upcoming November Investor Conferences
November 04, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 28, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 27, 2025
Via
Benzinga
Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference
October 24, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis
October 21, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference
October 01, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer
September 08, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Reports Second Quarter 2025 Financial Results
August 11, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Hut 8, Greenbrier And Other Big Stocks Moving Higher On Tuesday
↗
July 02, 2025
Via
Benzinga
Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model
June 06, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Newly-Listed Sionna Therapeutics Touts Positive Data From Lung Disease Candidate In Healthy Volunteer Trial
↗
June 04, 2025
Via
Benzinga
Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis
June 04, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
June 03, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics to Present Preclinical Data During Oral Session at the 48th European Cystic Fibrosis Conference
May 22, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics Reports First Quarter 2025 Financial Results
May 12, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025
April 30, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
April 22, 2025
Via
Benzinga
Alcoa Posts Weak Revenue, Joins QXO And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
April 17, 2025
Via
Benzinga
Why Liberty Energy Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
↗
April 17, 2025
Via
Benzinga
Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
March 20, 2025
From
Sionna Therapeutics, Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Sionna Therapeutics, Inc. - Common Stock publicly traded?
Yes, Sionna Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Sionna Therapeutics, Inc. - Common Stock trade on?
Sionna Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sionna Therapeutics, Inc. - Common Stock?
The ticker symbol for Sionna Therapeutics, Inc. - Common Stock is SION on the Nasdaq Stock Market
What is the current price of Sionna Therapeutics, Inc. - Common Stock?
The current price of Sionna Therapeutics, Inc. - Common Stock is 35.60
When was Sionna Therapeutics, Inc. - Common Stock last traded?
The last trade of Sionna Therapeutics, Inc. - Common Stock was at 01/12/26 11:25 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
